The comparison of the effect of ondansetron and amisulpride on post operative nausea and vomiting (PONV) in general abdominal surgeries

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210926052599N1

Enrollment

116

Registered

2021-10-19

Start date

2021-10-23

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: Intervention group: The first group will be injected intravenously at 5 mg of Amisulpride within half an hour before the surgery. Intervention 2: Control group: The second group will b

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Indication for general anesthesia Being in American Society of Anesthesiologists (ASA) 1,2 anesthesia class Patient satisfaction to participate in the study Possibility of follow-up within 24 hours after abdominal surgery 18.5< Body mass index (BMI) <30

Exclusion criteria

Exclusion criteria: Advanced underlying disease Patient dissatisfaction to participate in the study Catching Motion sickness Excessive bleeding during surgery Severe postoperative complications

Design outcomes

Primary

Measure	Time frame
Efficacy of medication on postoperative nausea and vomiting. Timepoint: 24 hours after surgery. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireaz Momennia

Islamic Azad University

rudsar93@gmail.com+98 13 4262 4156

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026